Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Home
Ondine Biomedical, Inc.
PDMR Dealing
Published Nov 4 2022
3 min read

PDMR Dealing

4 November 2022

 

Ondine Biomedical Inc.
("Ondine Biomedical", "Ondine" or the "Company")

PDMR Dealing

Ondine Biomedical Inc. (AIM: OBI), announces the following dealings a person discharging managerial responsibilities ('PDMR'):

On 2 November 2022, Vipul Shah, Chief Financial Officer of Ondine, purchased 15,000 ordinary shares with no par value at a price of 24.5 pence per share. Following this purchase, Mr Shah's total interest in the Company is 65,000 Ordinary Shares, representing 0.033% of the total voting rights of the Company.

The notification below, made in accordance with the requirements of the UK Market Abuse Regulations, provides further detail in respect of the transaction as described above.

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Vipul Shah

2.

Reason for the Notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ondine Biomedical Inc.

b)

LEI

9845005B69E07CGF4A56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv)each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of no par value

Identification code

GB00BYX5K988

b)

Nature of the Transaction

Purchase of ordinary shares

c)

Price(s) and volume(s)

  Price(s)

Volume(s)

24.5 pence

15,000

d)

Aggregated information

Aggregated volume Price

As above

 

e)

Date of the transaction

2.11.2022

f)

Place of the transaction

AIM (LSE)

 

For further Information, please visit: www.ondinebio.com or contact:

 

Ondine Biomedical Inc. 

 

Carolyn Cross, CEO

+1 604 669 0555

 

 

Strand Hanson Limited (Nominated and Financial Adviser)

 

James Harris, James Dance, Richard Johnson

+44 (0) 20 7409 3494 

 

 

RBC Capital Markets (Joint Broker)

 

Rupert Walford, Kathryn Deegan

+44 (0) 20 7653 4000


 

Singer Capital Markets (Joint Broker)

 

Aubrey Powell, Asha Chotai 

+44 (0)20 7496 3000



Vane Percy & Roberts (Media Contact)


Simon Vane Percy, Amanda Bernard

+44 (0) 77 1000 5910